PMC8635634_01
Changes in PSA levels and medications after diagnosis.
fonc-11-736975-g001.jpg
PMC8635634_01_fonc-11-736975-g001.jpg
f1
At the October 2020 admission, the patient's PSA level was elevated again due to disease progression ( Figure 1 ).
(A) Redness and swelling around the eyes; (B) Diffuse erythematous plaques involving perianal area; (C) Close-up view of the topical eruption.
fonc-11-736975-g002.jpg
PMC8635634_01_fonc-11-736975-g002.jpg
f2
Ten days after starting therapy, a physical examination found erythematous macules on his perineum, redness and swelling around the eyes, as well as facial edema ( Figure 2 ).
(A) Before treatment: diffuse erythema on the back; (B) After treatment: erythema basically disappeared.
fonc-11-736975-g003.jpg
PMC8635634_01_fonc-11-736975-g003.jpg
f3
Two days later, the lesions evolved to diffuse erythematous plaques all over the body ( Figure 3A ). After 12 days of stopping enzalutamide, systemic erythema significantly alleviated, and the skin surface appeared desquamated ( Figure 3B ).